Home / Stocks / IQV

IQVIA Holdings (IQV, Life Sciences Tools & Services) Stock Valuation & Fair Value Trading above fair value

IQVIA Holdings (IQV, Life Sciences Tools & Services) trades at a blended P/E of 20.4, about 6% below its historical normal valuation, with a forward growth estimate of 11.3% and a PEG of 1.81. Analysts' one-year estimates have been hit 73% of the time.

DATA AS OF 2026-08-21
Blended P/E
20.4
Normal P/E
21.8
PEG
1.81
Fwd growth
11.3%
Div yield
0.0%
RSI (14)
72.7
Overbought

The Street vs SeerForecast

Wall Street's mean price target for IQV is $275.17 across 18 analysts, 5.9% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: trading above fair value. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from fairly valued (2026-06-03) to trading above fair value (2026-08-21).

Price and rating by weekClose moved +30.0 percent from 2026-06-03 to 2026-08-17, with 0 rating changes over 21 recorded weeks.2026-06-03: Fairly valued, close 182.05 (recalculated)2026-06-10: Fairly valued, close 182.17 (recalculated)2026-06-14: Fairly valued, close 181.46 (recalculated)2026-06-16: Fairly valued, close 179.17 (recalculated)2026-06-21: Fairly valued, close 167.77 (recalculated)2026-07-02: Fairly valued, close 207.04 (recalculated)2026-07-06: Fairly valued, close 205.97 (recalculated)2026-07-09: Fairly valued, close 208.97 (recalculated)2026-07-12: Fairly valued, close 207.85 (recalculated)2026-07-13: Fairly valued, close 207.55 (recalculated)2026-07-14: Fairly valued, close 207.83 (recalculated)2026-07-20: Fairly valued, close 203.90 (recalculated)2026-07-22: Fairly valued, close 198.52 (recalculated)2026-07-25: Fairly valued, close 208.05 (recalculated)2026-07-27: Fairly valued, close 213.22 (recalculated)2026-07-31: Fairly valued, close 235.02 (recalculated)2026-08-03: Fairly valued, close 235.022026-08-07: Fairly valued, close 238.70 (recalculated)2026-08-10: Fairly valued, close 238.702026-08-14: Fairly valued, close 236.66 (recalculated)2026-08-17: Fairly valued, close 236.661822372026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 14.7-32%Fairly valued
2026-06-10P/E 14.9-32%Fairly valued
2026-06-14P/E 14.9-32%Fairly valued
2026-06-16P/E 14.9-32%Fairly valued
2026-06-21P/E 14.9-32%Fairly valued
2026-07-02P/E 16.4-25%Fairly valued
2026-07-06P/E 16.7-23%Fairly valued
2026-07-09P/E 16.7-23%Fairly valued
2026-07-12P/E 16.8-23%Fairly valued
2026-07-13P/E 16.8-23%Fairly valued
2026-07-14P/E 16.8-23%Fairly valued
2026-07-20P/E 16.6-24%Fairly valued
2026-07-22P/E 16.6-24%Fairly valued
2026-07-25P/E 16.7-23%Fairly valued
2026-07-27P/E 16.7-23%Fairly valued
2026-07-31P/E 19.0-13%Fairly valued
2026-08-03P/E 18.8-14%Fairly valued
2026-08-07P/E 18.6-15%Fairly valued
2026-08-10P/E 19.1-13%Fairly valued
2026-08-14P/E 19.3-12%Fairly valued
2026-08-17P/E 19.3-12%Fairly valued
2026-08-21P/E 20.4-6%Trading above fair value ← now

Frequently asked questions

Is IQVIA Holdings stock overvalued?

At a blended P/E of 20.4 versus its historical normal P/E of 21.8, IQVIA Holdings trades about 6% below its typical valuation, with a PEG of 1.81 on 11.3% forward growth. tickerseer currently rates it trading above fair value.

What is IQVIA Holdings's fair value and PEG?

IQVIA Holdings trades at a blended P/E of 20.4 against a historical normal P/E of 21.8, a PEG of 1.81, and a forward growth estimate of 11.3%.

Has tickerseer's rating of IQVIA Holdings changed?

tickerseer's rating moved from fairly valued (2026-06-03) to trading above fair value (2026-08-21).

What is the analyst price target for IQVIA Holdings?

The mean Wall Street price target for IQVIA Holdings is $275.17 across 18 analysts, 5.9% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track IQV free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.